Abbott Laboratories (ABT)
Financial leverage ratio
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 73,214,000 | 72,090,000 | 73,354,000 | 73,794,000 | 74,438,000 | 72,801,000 | 74,202,000 | 74,007,000 | 75,196,000 | 73,795,000 | 73,269,000 | 72,785,000 | 72,548,000 | 69,043,000 | 68,776,000 | 66,777,000 | 67,887,000 | 68,539,000 | 68,427,000 | 67,610,000 |
| Total stockholders’ equity | US$ in thousands | 38,603,000 | 37,481,000 | 37,174,000 | 37,010,000 | 36,686,000 | 35,675,000 | 36,490,000 | 35,399,000 | 35,802,000 | 34,422,000 | 33,800,000 | 33,562,000 | 32,784,000 | 31,386,000 | 30,578,000 | 30,218,000 | 31,088,000 | 31,817,000 | 31,686,000 | 30,925,000 |
| Financial leverage ratio | 1.90 | 1.92 | 1.97 | 1.99 | 2.03 | 2.04 | 2.03 | 2.09 | 2.10 | 2.14 | 2.17 | 2.17 | 2.21 | 2.20 | 2.25 | 2.21 | 2.18 | 2.15 | 2.16 | 2.19 |
December 31, 2023 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $73,214,000K ÷ $38,603,000K
= 1.90
Abbott Laboratories' financial leverage ratio has been trending slightly downwards over the past few quarters, indicating a modest reduction in the company's reliance on debt to finance its operations. The ratio decreased from 2.09 in Q1 2022 to 1.90 in Q4 2023, suggesting that Abbott Laboratories has been able to effectively manage its debt levels and possibly strengthen its financial position. A lower financial leverage ratio typically implies lower financial risk and greater stability for the company. Overall, the decreasing trend in Abbott Laboratories' financial leverage ratio indicates a positive development in the company's capital structure.
Peer comparison
Dec 31, 2023